-
Rhodamine B for Drift Tracing and Cell Imaging
2026-09-14
Rhodamine B converts invisible spray movement into measurable fluorescence, enabling UAV-versus-knapsack comparisons and practical drift-risk mapping. Its high solubility and established biological use also support cell-labeling screens, microscopy, and fluorescence-based assay development when matrix-specific controls are applied.
-
Lambda Protein Phosphatase for BMAL1 Assays
2026-09-14
Use Lambda Protein Phosphatase to distinguish phosphorylation-dependent BMAL1 behavior from antibody, abundance, and condensate artifacts. This practical workflow combines paired dephosphorylation controls with circadian phase-separation assays, antibody validation, and functional follow-up.
-
UPF3A Expression Across Mouse Tissues
2026-09-13
This study challenges the prevailing view that UPF3A is largely restricted to testis by quantitatively comparing UPF3A and UPF3B protein expression across mouse tissues. Its findings support a broader role for UPF3A in tissue homeostasis and refine how researchers interpret paralog-specific regulation within nonsense-mediated mRNA decay.
-
Phebestin: Multistage Antiplasmodial Evidence
2026-09-12
The reference study identifies phebestin, a bestatin-related aminopeptidase inhibitor, as a nanomolar antiplasmodial candidate active against both chloroquine-sensitive and chloroquine-resistant Plasmodium falciparum. Its activity across parasite stages, persistence after washout, proposed binding to parasite aminopeptidases, and partial efficacy in infected mice provide a useful framework for evaluating next-generation malaria research chemicals.
-
Metoprolol Workflows for Cardiovascular Research
2026-09-11
Metoprolol provides a practical way to isolate beta1-adrenergic signaling while connecting cardiovascular, inflammatory, and tumor-biology assays. This guide combines concentration-response experiments, tissue-distribution logic, transporter controls, and troubleshooting strategies informed by a recent integrated pharmacokinetic study.
-
ssBIR and DNA Damage Amplification in Mouse Oocytes
2026-09-11
The reference study identifies short-scale break-induced replication (ssBIR) in fully grown mouse oocytes and shows that DNA double-strand breaks can be amplified through Rad51-dependent repair and DNA synthesis. Its combination of EdU imaging, DNA-damage markers, and replication inhibitors provides a useful framework for distinguishing localized repair synthesis from broader genome-damage responses.
-
Prostaglandin E2 in Inflammation Assays
2026-09-10
Build more interpretable inflammation experiments with Prostaglandin E2 by combining receptor-aware dosing, solvent controls, and time-resolved readouts. The workflow also shows how PGE2 can complement hydrogel-based intervertebral disc degeneration models without confusing assay extension with evidence of therapeutic efficacy.
-
SAF312 TRPV1 Antagonism in Ocular Surface Pain
2026-09-10
Mogi and colleagues developed a translational preclinical profile for SAF312 (libvatrep), a potent, selective, noncompetitive antagonist of human TRPV1 designed for topical treatment of ocular surface pain. The study connected receptor pharmacology with ocular distribution, tolerability, and post-PRK wound-healing data, supporting further clinical evaluation while leaving efficacy in patients to be established.
-
Zolmitriptan: From Receptor Probe to Assay Design
2026-09-09
Zolmitriptan is a selective 5-HT1B receptor agonist used to dissect migraine and cluster headache biology. This guide goes beyond routine compound handling by showing how orthogonal assay design and insights from lysosomal antiviral research can improve serotonin receptor pharmacology without overextending the evidence.
-
Prostaglandin E2: Receptor Biology to Assays
2026-09-09
Explore how Prostaglandin E2 and its EP-receptor profile can be translated into better inflammation research assays. This article connects receptor pharmacology with the compartment-specific lessons of ulcerative-colitis drug delivery.
-
CDC42, NTCP Trafficking, and HBV Entry
2026-09-08
The reference study identifies CDC42 as a regulator of hepatitis B virus entry through two linked processes: Rab11-dependent delivery of NTCP to the plasma membrane and CDC42-dependent macropinocytosis. Its findings separate this pathway from clathrin-mediated endocytosis and provide a mechanistic framework for studying how host membrane trafficking controls HBV susceptibility.
-
SLC25A1, H3K27ac, and Cisplatin Resistance in HNSCC
2026-09-08
A 2026 npj Precision Oncology study links SLC25A1 upregulation to cisplatin resistance in head and neck squamous cell carcinoma through citrate-dependent acetyl-CoA production, H3K27ac-mediated transcription, and cellular senescence. The findings position SLC25A1 as a candidate biomarker and therapeutic target while highlighting the need for carefully controlled senescence and lysosomal β-galactosidase assays.
-
Neuromedin S (rat): Practical GPCR Assay Guide
2026-09-07
This guide provides practical handling, reconstitution, assay setup, and quality-control guidance for Neuromedin S (rat), SKU B5466, when no directly matched paper evidence is available. It supports controlled neuromedin U receptor and GPCR/G protein signaling research, but not diagnostic, therapeutic, or medical use.
-
Pifithrin-α: Mapping p53 in Ferroptosis
2026-09-07
A translational perspective on Pifithrin-α as a research-grade p53 inhibitor for separating apoptosis, ferroptosis, DNA-damage responses, and radioprotection mechanisms.
-
Benzyl-activated Streptavidin Magnetic Beads
2026-09-05
Benzyl-activated Streptavidin Magnetic Beads (SKU: K1301) provide magnet-assisted capture of biotinylated proteins, nucleic acids, peptides, antibodies, and other targets from complex samples. They are suitable for affinity purification, immunoprecipitation, interaction assays, and screening, but preservative compatibility, elution conditions, and performance with non-biotinylated or highly hydrophobic samples require validation.